x

Posted 15 September, 2023

DocGo Inc. appointed Lee Bienstock as new CEO

Nasdaq:DCGO appointed new Chief Executive Officer Lee Bienstock in a 8-K filed on 15 September, 2023.


  On September 15, 2023, the Board of Directors of the Company (the "Board") appointed Lee Bienstock, the Company's current President and Chief Operating Officer, as the Chief Executive Officer of the Company, effective immediately.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of DocGo Inc.
Health Care/Life Sciences • Healthcare Provision
DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.
Market Cap
$378M
View Company Details
DocGo Inc. by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


(a) Resignation of Chief Executive Officer 


On September 15, 2023, effective immediately, Anthony Capone resigned as the Chief Executive Officer of DocGo Inc. (the "Company") and from all other positions with the Company due to personal reasons.


(b) Appointment of Chief Executive Officer 


On September 15, 2023, the Board of Directors of the Company (the "Board") appointed Lee Bienstock, the Company's current President and Chief Operating Officer, as the Chief Executive Officer of the Company, effective immediately. The position of President and Chief Operating Officer will remain vacant.


The information regarding Mr. Bienstock required by Items 401(b) and (e) of Regulation S-K is incorporated by reference to the Company's proxy statement filed with the Securities and Exchange Commission on April 26, 2023. There are no family relationships between Mr. Bienstock, on the one hand, and any director or executive officer of the Company, on the other hand. Mr. Bienstock has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.